Home›Companies›Biotech & Pharma›PTX

Platform Therapeutics, Inc.

Develops treatments for patients affected by chemotherapy toxicity and dialysis-related muscle cramps.

Updated Nov 9, 2026·Latest SEC filing Aug 27, 2026·Suggest an edit

About PTX

PTX is a private company based in Andover, Massachusetts, incorporated in 2022 in Delaware. It has reported $1,750,000 raised in one offering on Form D since August 2026. Its chief executive is James Wilkie.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 12, 2026Aug 27, 2026$1,750,000of $4.0M target1$1.7MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PTX's Form D filed Aug 27, 2026.

JW
James Wilkie
Founder & CEO, director
LC
Lakhmir Chawla
Founder, Chairman, & CMO
Also a director at ExThera Medical.

Sources

  1. SECPlatform Therapeutics, Inc. filing history
  2. CompanyPrivacy policy
  3. CompanyAbout Platform Therapeutics